ストックスクリーナーアプリを入手
1.08
3.57%
-0.04
アフターアワーズ：
1.08
前日終値:
$1.12
開ける：
$1.14
24時間の取引高:
1.28M
Relative Volume:
0.74
時価総額：
$103.48M
収益：
-
当期純損益:
$-93.61M
株価収益率:
-0.5118
EPS:
-2.11
ネットキャッシュフロー:
$-71.16M
1週間 パフォーマンス:
+15.93%
1か月 パフォーマンス:
+54.29%
6か月 パフォーマンス:
+10.15%
1年 パフォーマンス:
-25.52%
1日の値動き範囲:
$1.06
$1.18
1週間の範囲:
$0.9334
$1.18
52週間の値動き範囲:
$0.561
$2.11
Immunic Inc Stock (IMUX) Company Profile
IMUX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IMUX
Immunic Inc
|
1.08 | 107.32M | 0 | -93.61M | -71.16M | -2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-25 | 開始されました | William Blair | Outperform |
| 2024-11-25 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-09 | 再開されました | Leerink Partners | Outperform |
| 2024-08-27 | 開始されました | B. Riley Securities | Buy |
| 2022-10-21 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-19 | 再開されました | H.C. Wainwright | Buy |
| 2021-04-15 | 開始されました | Aegis Capital | Buy |
| 2021-03-24 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-10-02 | 開始されました | SVB Leerink | Outperform |
| 2020-08-26 | 開始されました | Piper Sandler | Overweight |
| 2020-08-07 | 再開されました | ROTH Capital | Buy |
| 2020-07-20 | 開始されました | BMO Capital Markets | Outperform |
| 2020-06-05 | 開始されました | Wedbush | Outperform |
| 2020-05-11 | 開始されました | H.C. Wainwright | Buy |
| 2020-03-25 | 開始されました | ROTH Capital | Buy |
| 2019-07-11 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Immunic Inc (IMUX) 最新ニュース
What is the dividend policy of Immunic Inc. stockBuild wealth with long-term growth strategies - jammulinksnews.com
What are analysts’ price targets for Immunic Inc. in the next 12 monthsCapitalize on emerging market trends - jammulinksnews.com
Should I hold or sell Immunic Inc. stock in 2025Triple-digit profit margins - jammulinksnews.com
Is it the right time to buy Immunic Inc. stockFree Predictions - jammulinksnews.com
When is Immunic Inc. stock expected to show significant growthIdentify safe investments with exceptional yields - jammulinksnews.com
Is Immunic Inc. a growth stock or a value stockAchieve rapid portfolio growth with smart picks - jammulinksnews.com
What are the technical indicators suggesting about Immunic Inc.Free Consultation - jammulinksnews.com
What is Immunic Inc. company’s growth strategyBreakthrough profit margins - jammulinksnews.com
Immunic, Inc.'s (NASDAQ:IMUX) market cap touched US$103m last week, benefiting both individual investors who own 55% as well as institutions - simplywall.st
Immunic Reports Positive Long-Term Safety, Tolerability Data for Vidofludimus Calcium in MS Trial - Yahoo Finance
What drives Immunic Inc. stock priceRapid return acceleration - Autocar Professional
What analysts say about Immunic Inc. stockRecord-breaking gains - PrintWeekIndia
How Immunic Inc. stock reacts to Fed policy changesPowerful profit generation - jammulinksnews.com
Immunic Inc. Stock Analysis and ForecastRapid growth opportunities - Autocar Professional
How high can Immunic Inc. stock price go in 2025Accelerated earnings growth - jammulinksnews.com
Is Immunic Inc. a good long term investmentBreakthrough profits - PrintWeekIndia
Immunic, Inc. shares fall 2.01% premarket after AstraZeneca's immune disorder drug succeeds in late-stage trial. - AInvest
12 Best Penny Stocks Under $1 to Buy Now - Insider Monkey
World Brain Day: Immunic targets MS with new therapy - Proactive financial news
IMUX’s Stock Market Puzzle: Piecing Together 2025’s Performance - investchronicle.com
What makes Immunic Inc. stock price move sharplyValue Pick Scanner - Newser
How Immunic Inc. stock performs during market volatilityFree Top Growth Stock Recommendations - Newser
Why Immunic Inc. stock attracts strong analyst attentionFree Capital Allocation Plans - Newser
Immunic Inc (IMUX) 財務データ
収益
当期純利益
現金流量
EPS
1.32%
1.06%
大文字化:
|
ボリューム (24 時間):